Roughly half of men around the age of 50 have an enlarged prostate, and could cause urinary issues if left unchecked.
A poorly characterized protein, historically thought to be a chaperon or enzyme, may actually be a key player in prostate ...
News-Medical.Net on MSN
PTGES3 emerges as key regulator of androgen receptor in prostate cancer
A poorly characterized protein, historically thought to be a chaperone or enzyme, may actually be a key player in prostate ...
Bill Gates shares personal insights on Alzheimer’s and a new FDA-approved blood test that could revolutionize early diagnosis ...
Every year, the University of Kansas Cancer Center must file a report with the National Cancer Institute in order to get its annual grant allotment.
IDT Biologika GmbH (IDT), the European subsidiary of SK bioscience, has embarked on a full-scale drive to expand its global contract development and manufacturing (CDMO) business in vaccines and ...
The Hearty Soul on MSN
Woman with Stage 4 Cancer Refuses Chemotherapy in Favor of 21-Day Water Fast: ‘People Will Judge, But I Believe It's Right for Me'
A cancer diagnosis forces us to make decisions that we never imagined ourselves making. This is especially when the regular ...
Satsuma Pharmaceuticals, Inc., a late-stage biopharmaceutical company and its corporate parent, Shin Nippon Biomedical Laboratories, Ltd. (TSE:2395) are dedicated to bringing novel treatments to ...
Pharmaceutical Technology on MSN
MSD secures $700m for broad-cancer ADC asset
ADCs remain à la mode in the oncology sector, with Merck & Co (MSD) tying up another deal to advance its pipeline in the ...
We are conducting a two-part exploration of Benign Prostatic Hyperplasia (BPH), reviewing both the historical and the forward ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback